Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
Clinical trial NCT04720183 · COMPLETED
Trial details
- NCT number
- NCT04720183
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-04-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.